Metronet Names New CEO, CFO
Company Executes Succession Plan; Prepares for Future Growth EVANSVILLE, Ind.–(BUSINESS WIRE)–Metronet announced today the advancement…
ISP
USISPF, ReNew and the Consulate General of India Bring Together Business and Government Leaders to Discuss U.S.- India Climate Partnership
NEW YORK–(BUSINESS WIRE)–$RNW #ClimatePartnership–The US-India Strategic Partnership Forum (USISPF), and ReNew, in partnership with the…
Epic Bio to Present at Upcoming BMO Biopharma Spotlight Series Event
SOUTH SAN FRANCISCO, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) — Epic Bio, a biotechnology company…
Epic Bio to Present at Upcoming BMO Biopharma Spotlight Series Event
SOUTH SAN FRANCISCO, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) — Epic Bio, a biotechnology company…
ADOCIA Announces First Half 2023 Financial Results and Provides a Business Update
As of June 30, 2023 Cash position of €12.1 million (€17.4 million as of December…
Epic Bio Reports Discovery of Exceptionally Durable Gene Activators and Creation of Machine Learning Algorithm to Design New Activators
– Vast high-throughput screening study used to train unique machine learning algorithm to design synthetic…
iSpecimen Expands Provider Network to Enhance Support for Women’s Health Research
Additional Providers Increase Biospecimen Access for Researchers Focused on Cervical, Uterine and Breast Cancers, as…
iSpecimen Expands Provider Network to Enhance Support for Women’s Health Research
Additional Providers Increase Biospecimen Access for Researchers Focused on Cervical, Uterine and Breast Cancers, as…
CRISPR Therapeutics Announces Leadership Transition
-CRISPR Therapeutics co-founder, Rodger Novak, M.D., to step down as President and Chairman, effective September…
CRISPR Therapeutics Announces Leadership Transition
-CRISPR Therapeutics co-founder, Rodger Novak, M.D., to step down as President and Chairman, effective September…
iSpecimen Announces Organizational Changes to Enhance Operational Efficiencies and Drive Profitability
Company to Focus on Core Revenue Drivers, New Revenue Growth Opportunities from Recently Launched Sequencing…
Editas Medicine Announces Upcoming Investor Events
CAMBRIDGE, Mass., Aug. 30, 2023 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage…
Editas Medicine Announces Upcoming Investor Events
CAMBRIDGE, Mass., Aug. 30, 2023 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage…
Ubiquiti Inc. Reports Fourth Quarter Fiscal 2023 Financial Results
~ Revenues of $491.1 million ~ ~ GAAP Diluted Earnings Per Share of $1.72 ~…
TransCode Therapeutics Announces First Subject Dosed with Radiolabeled TTX-MC138 in First-In-Human Clinical Trial
Designed to demonstrate delivery of TTX-MC138 to metastatic lesions BOSTON, Aug. 23, 2023 (GLOBE NEWSWIRE)…
TransCode Therapeutics Announces First Subject Dosed with Radiolabeled TTX-MC138 in First-In-Human Clinical Trial
Designed to demonstrate delivery of TTX-MC138 to metastatic lesions BOSTON, Aug. 23, 2023 (GLOBE NEWSWIRE)…
Excision BioTherapeutics Announces Gene Therapy Publication of Pre-Clinical Data Supporting its First-in-Class CRISPR-Based Gene Therapy Candidate Designed to Functionally Cure HIV-1
Results demonstrate safety, biodistribution, and on-target editing of simian immunodeficiency virus (SIV) in non-human primates…
Excision BioTherapeutics Announces Gene Therapy Publication of Pre-Clinical Data Supporting its First-in-Class CRISPR-Based Gene Therapy Candidate Designed to Functionally Cure HIV-1
Results demonstrate safety, biodistribution, and on-target editing of simian immunodeficiency virus (SIV) in non-human primates…
iSpecimen Enhances Proprietary Marketplace Platform to Streamline Biospecimen Matchmaking for Researchers and Providers
New Capabilities Enable Platform to Efficiently Collect and Store Most Up-to-Date Data from Providers and…
iSpecimen Enhances Proprietary Marketplace Platform to Streamline Biospecimen Matchmaking for Researchers and Providers
New Capabilities Enable Platform to Efficiently Collect and Store Most Up-to-Date Data from Providers and…